Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)

Scandinavian ChemoTech AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	99	117	42	44	61	164
Market Cap Growth	210.74%	180.45%	-4.97%	-27.52%	-63.02%	100.32%
Enterprise Value	95	113	40	43	59	149
Last Close Price	3.89	5.02	1.79	2.59	4.85	16.37
PS Ratio	8.06	9.54	6.36	15.58	128.26	63.47
PB Ratio	31.08	36.78	6.99	3.99	4.34	6.86
P/TBV Ratio	79.02	-	10.74	4.98	5.10	7.41
EV/Sales Ratio	7.76	9.19	6.12	15.17	124.92	57.70
Debt / Equity Ratio	-	-	-	-	-	0.00
Net Debt / Equity Ratio	-1.15	-1.15	-0.16	-0.08	-0.42	-0.36
Net Debt / EBITDA Ratio	0.82	0.82	0.08	0.05	0.28	0.51
Net Debt / FCF Ratio	0.98	0.98	0.05	0.05	0.30	0.45
Asset Turnover	0.92	0.92	0.47	0.15	0.02	0.12
Inventory Turnover	0.65	0.65	0.49	0.33	0.20	-
Quick Ratio	0.63	0.63	0.38	0.54	0.98	5.40
Current Ratio	0.91	0.91	1.05	1.88	1.53	7.10
Return on Equity (ROE)	-175.78%	-175.78%	-161.27%	-168.57%	-120.00%	-107.04%
Return on Assets (ROA)	-30.39%	-30.39%	-56.62%	-69.17%	-55.02%	-51.07%
Return on Capital Employed (ROCE)	-202.90%	-202.90%	-214.00%	-183.50%	-149.50%	-71.40%
Earnings Yield	-8.14%	-6.87%	-32.83%	-47.97%	-37.49%	-10.81%
FCF Yield	-3.91%	-3.19%	-43.62%	-41.45%	-32.12%	-11.72%
Buyback Yield / Dilution	-16.32%	-16.32%	-53.13%	-35.31%	-15.17%	-75.79%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.